Takeda: all 1,753 studies
Page 15 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.
- Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory SupportCompletedNCT01861795
- EDEMA2: Evaluation of DX-88's Effect in Mitigating AngioedemaCompletedNCT01826916Phase 2
- Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)CompletedNCT01822184
- Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid TumorsCompletedNCT01765790Phase 1
- SYR-472 Open-label StudyCompletedNCT01751360Phase 3
- Intralymphatic eASC Administration in Healthy VolunteersCompletedNCT01743222Phase 1
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BActive, not recruitingNCT01687608Phase 1/2
- A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322CompletedNCT01686711Phase 4
- A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 DisorderWithdrawnNCT01685151Phase 3
- Prucalopride Subjects With Renal ImpairmentCompletedNCT01674192Phase 1
- Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01674166Phase 1
- Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01670669Phase 1
- Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis PatientsCompletedNCT01663116Phase 1/2
- A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)TerminatedNCT01661387
- Double-blind Comparative Study of SYR-472CompletedNCT01632007Phase 3
- A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive EsophagitisCompletedNCT01630746Phase 3
- Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic MalignanciesWithdrawnNCT01613261Phase 1
- BAX 855 Dose-Escalation Safety StudyCompletedNCT01599819Phase 1
- A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell DiseaseCompletedNCT01597401Phase 1
- Expanded Access Program of PonatinibApproved for marketingNCT01592136
- Double Blind Comparative Study of TAK-875CompletedNCT01585792Phase 3
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin TherapyCompletedNCT01568398Phase 3
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) TherapyCompletedNCT01568385Phase 3
- Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus NephritisTerminatedNCT01541670Phase 1
- Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseCompletedNCT01541579Phase 3
- A European Post-Authorisation Observational Study Of Patients With Hereditary AngioedemaCompletedNCT01541423
- Study of Combination Therapy With SYR-322CompletedNCT01521962Phase 3
- Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)CompletedNCT01509768
- Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. PyloriCompletedNCT01505127Phase 3
- Phase 1/2 Lyme Vaccine StudyCompletedNCT01504347Phase 1/2
- Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid InhibitionWithdrawnNCT01499693Phase 3
- A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy SubjectsCompletedNCT01497288Phase 1
- TAK-875 Glimepiride Drug-Interaction StudyCompletedNCT01496443Phase 1
- Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux DiseaseCompletedNCT01474369Phase 3
- FST-100 in the Treatment of Acute Adenoviral ConjunctivitisCompletedNCT01470664Phase 2
- FST-100 in the Treatment of Acute Viral ConjunctivitisCompletedNCT01461954Phase 2
- Osteoporosis and MRI Study in HemophiliaTerminatedNCT01460147Not applicable
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01459367Phase 3
- Efficacy and Safety of TAK-385 in the Treatment of EndometriosisCompletedNCT01458301Phase 2
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01456260Phase 3
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01456247Phase 3
- Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly ParticipantsCompletedNCT01456117Phase 1
- Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01452776Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01452763Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01452750Phase 3
- Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal UlcerCompletedNCT01452724Phase 3
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric UlcerCompletedNCT01452711Phase 3
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive EsophagitisCompletedNCT01452698Phase 3
- A Long-term Extension Study of TAK-385 in the Treatment of EndometriosisCompletedNCT01452685Phase 2
- Efficacy and Safety of TAK-385 in the Treatment of Uterine FibroidsCompletedNCT01452659Phase 2
- Open-label Study of TAK-875CompletedNCT01433419Phase 3
- Long-term Study of TAK-875CompletedNCT01433406Phase 3
- Double-blind Comparative Study of TAK-875CompletedNCT01433393Phase 3
- Long-term Study of SYR-472CompletedNCT01431807Phase 3
- This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT01419379
- Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusCompletedNCT01414920Phase 2
- Immune Globulin Subcutaenous (Human), 20%CompletedNCT01412385Phase 2/3
- Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCompletedNCT01395147Phase 3
- VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid ArthritisTerminatedNCT01390545Phase 2
- Multiple Ascending Dose Trial of BYK324677 in Healthy VolunteersCompletedNCT01386541Phase 1
- Study of TAK-816 in Healthy InfantsCompletedNCT01379846Phase 3
- Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's DiseaseTerminatedNCT01378390Phase 3
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.CompletedNCT01372969Phase 1/2
- Home Therapy With VPRIV in Gaucher's DiseaseCompletedNCT01356537
- Home Therapy With Replagal in Fabry DiseaseCompletedNCT01355146
- TAK-329 Glucose Clamp StudyCompletedNCT01311076Phase 1
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedNCT01289132Phase 2
- Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)WithdrawnNCT01274221Phase 3
- Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary AngioedemaWithdrawnNCT01253382Phase 2/3
- SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of SchizophreniaWithdrawnNCT01234298Phase 3
- Efficacy of Tinoridine in Treating Pain and Inflammation in AdultsCompletedNCT01224756Phase 4
- Sophisticated Assessment of Disease Burden in Patients With Fabry DiseaseCompletedNCT01210196
- A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral DefectsTerminatedNCT01209390
- Effect of Teduglutide on Gastric Emptying in Healthy SubjectsCompletedNCT01209351Phase 1
- A Study of TAK-441 in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT01204073Phase 1
- Study of the Safety and Efficacy of MLN1202 in Patients in Multiple SclerosisCompletedNCT01199640Phase 2
- Pediatric Disease Registry in Essential Thrombocythaemia (ET)CompletedNCT01198717
- Surveillance Study of Patients With Newly Diagnosed OsteosarcomaTerminatedNCT01194284
- First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia PatientsTerminatedNCT01191372Phase 1
- Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or NormonatraemiaCompletedNCT01179607Phase 2
- Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant ReversalCompletedNCT01159210Phase 4
- Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic ImpairmentCompletedNCT01134185Phase 1
- Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT01132638Phase 3
- Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448TerminatedNCT01132404Phase 1/2
- IMMUNINE Pre-Treatment StudyCompletedNCT01128881Phase 4
- Ceprotin Treatment RegistryCompletedNCT01127529
- Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 DiabetesTerminatedNCT01124656Phase 3
- Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate CancerCompletedNCT01122121Phase 3
- Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom MacroglobulinemiaCompletedNCT01118689Phase 1
- An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)WithdrawnNCT01093105
- Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic ConstipationCompletedNCT01070615Phase 3
- Phase 1 Dosing Study of BAX 513 in Healthy VolunteersCompletedNCT01063101Phase 1
- Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific AntigenCompletedNCT01046916Phase 2
- Instanyl® Non-Interventional StudyCompletedNCT01045603
- Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron OverloadCompletedNCT01039636Phase 1
- M0001 Effects on Oral Contraceptive Plasma LevelsCompletedNCT01036893Phase 1
- Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)CompletedNCT01034969
- Treatment Protocol of Replagal for Patients With Fabry DiseaseNo longer availableNCT01031173
- Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female VolunteersCompletedNCT01028924Phase 1
- Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal FunctionCompletedNCT01028768Phase 1